The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

As per The Business Research Company’s Peptide Therapeutics Global Market Report 2024, the peptide therapeutics market is expected to show significant growth in the forecast period.

The peptide therapeutics market has experienced substantial growth in recent years and is poised for continued expansion. This blog explores the factors driving this growth, key trends, and future projections for the market.

Current Market Size and Growth Rate

• Market Size and Growth:
  • The peptide therapeutics market grew from $41.44 billion in 2023 to $45.66 billion in 2024, with a CAGR of 10.2%.
  • By 2028, the market is expected to reach $68.83 billion, growing at a CAGR of 10.8%.
• Historical Growth Drivers:
  • Increasing incidence of chronic diseases.
  • Growing understanding of molecular biology.
  • Expanding applications in oncology.

View More On The Peptide Therapeutics Market Report 2024 – https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report

Future Market Growth Drivers

• Rising Demand for Personalized Medicine:
  • Personalized medicine tailors treatments to individual patients, increasing the effectiveness of peptide therapeutics.
• Expanding Use in Immunotherapy:
  • Immunotherapy uses the body’s immune system to fight diseases, and peptides play a crucial role in these treatments.
• Advancements in Peptide Delivery Systems:
  • New delivery systems improve the efficacy and safety of peptide therapeutics.
• Emerging Peptide Targets in Infectious Diseases:
  • Peptides are being explored as treatments for various infectious diseases.
• Increasing Focus on Rare Diseases:
  • Peptide therapeutics offer potential treatments for rare and orphan diseases.

Trends Shaping the Future of Peptide Therapeutics

• Technological Advancements in Peptide Synthesis:
  • Innovations in synthesis techniques enhance the development of new peptide drugs.
• Growing Investment and Funding:
  • Increased funding supports research and development in peptide therapeutics.
• Emphasis on Peptide Drug Safety:
  • Ensuring the safety of peptide drugs is paramount to their success and adoption.
• Market Expansion in Emerging Economies:
  • Expanding into emerging markets offers significant growth opportunities.
• Integration of Artificial Intelligence (AI):
  • AI aids in the discovery and development of new peptide drugs.

Rising Prevalence of Chronic Diseases Propels Market Growth

• Chronic Diseases Driving Market Growth:
  • Chronic diseases are long-lasting conditions that are often controllable but not curable.
  • Increased use of tobacco, poor nutrition, physical inactivity, and excessive alcohol use contribute to chronic diseases.
• Peptide Therapeutics for Chronic Diseases:
  • Peptide therapeutics help prevent and treat various chronic diseases.
  • For example, the number of people aged 50 and older with at least one chronic condition in the US is projected to increase by 99.5% by 2050.

Key Players in the Peptide Therapeutics Market

• Major Companies:
  • Pfizer Inc.
  • Johnson & Johnson
  • AbbVie Inc.
  • Novartis AG
  • Bristol-Myers Squibb Company
  • AstraZeneca PLC
  • Amgen Inc.
  • Novo Nordisk AS
  • Teva Pharmaceuticals Industries Ltd.
  • Bachem Holding AG
  • PolyPeptide Laboratories BV
  • Arcus Biosciences Inc.
  • Anaptys Bio Inc.
  • Endoceutics Inc.
  • Pepscan Therapeutics
  • Peptech Inc.
  • Merck & Co Inc.

Innovative Advancements in Peptide Therapeutics

• Evonik’s Breakthrough in Cell Culture Processes:
  • In June 2023, Evonik Industries AG launched cQrex KC, a next-generation peptide for biopharma applications.
  • cQrex KC optimizes cystine supply and increases cell culture productivity, supporting the development of vaccines, viral vectors, and cell therapies.

Strategic Acquisitions and Market Expansion

• Bayer’s Acquisition of Vividion Therapeutics:
  • In August 2021, Bayer acquired Vividion Therapeutics to enhance its small molecule expertise and drug discovery capabilities.

Market Segmentation

• By Type:
  • Generic
  • Branded
• By Route of Administration:
  • Parenteral
  • Mucosal
  • Oral
  • Transdermal
• By Application:
  • Cancer
  • Cardiovascular Diseases
  • Central Nervous Systems
  • Metabolic Disorders
  • Infections
  • Hematological Disorders
  • Gastrointestinal Disorders
  • Dermatology
  • Respiratory Disorders
  • Acromegaly
  • Other Applications

Regional Insights

• North America:
  • North America was the largest region in the peptide therapeutics market in 2023.
• Asia-Pacific:
  • Asia-Pacific is expected to be the fastest-growing region during the forecast period.

Conclusion

The peptide therapeutics market is set for continued rapid growth, driven by rising prevalence of chronic diseases, advancements in technology, and expanding applications. With ongoing innovations and strategic expansions, the market is well-positioned to meet the growing demand for effective and personalized treatments.

Request A Sample Of The Global Peptide Therapeutics Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=7216&type=smp